Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Antispasmodics Drugs Industry?

The market size for antispasmodics drugs has shown robust growth in the past few years. It is anticipated to progress from $13.76 billion in 2024 to $14.93 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. The growth experienced in the historic period was due to an increase in spasmodic conditions, advancements in medical research, an expanding aged population, lifestyle shifts, and diagnostic improvements.

The market for antispasmodic drugs is projected to experience robust growth over the coming years, reaching a size of $21.44 billion in 2029 with a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period could be driven by factors such as surging healthcare spending, the rise of personalized medicine, the increase in global population, growth in emerging markets, and ongoing clinical trials and research. Key trends anticipated during the prediction period include broadening applications for antispasmodics, the progress of healthcare infrastructure, advancements in the field of drug development, growing awareness and diagnosis and a rising preference for non-invasive treatment methods.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9414&type=smp

#Which Factors Are Currently Driving The Growth Of The Antispasmodics Drugs Market?

The surge in the senior citizen population is anticipated to spur the expansion of the antispasmodic drug market. Those aged 65 and above fall into the elderly category and they often deal with a range of physical and psychological health ailments. Antispasmodics are beneficial in handling symptoms correlated with a myriad of conditions that could result in muscle spasms or cramping, and might also be utilized for treating diseases such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), interstitial cystitis, and uterine cramping. For example, the World Health Organization (WHO), a Switzerland-based global health body, stated in October 2022 that the global percentage of individuals aged 60 and above is poised to escalate to 1.4 billion by 2030. The quantity of people aged 60 and up will double by 2050, reaching 2.1 billion. Moreover, the count of individuals aged 80 and above is expected to witness a significant surge by 2050, totaling at 426 million. Hence, the rise in senior citizen count will serve as the driving factor for the antispasmodic drug market.

How Is The Global Antispasmodics Drugs Market Structured In Terms Of Segments?

The antispasmodics drugs market covered in this report is segmented –

1) By Drug: Dicyclomine Hydrochloride, Loperamide Hydrochloride, Other Drugs

2) By Indication: Irritable Bowel Syndrome, Stomach Cramps, Other Indications

3) By Route Of Administration: Oral, Parenteral, Other Modes Of Administrations

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Dicyclomine Hydrochloride: Oral Tablets, Injectable Formulations

2) By Loperamide Hydrochloride: Oral Tablets, Liquid Formulations

3) By Other Drugs: Hyoscine Butylbromide (Scopolamine), Peppermint Oil, Atropine, Other Antispasmodics

What Trends Are Currently Influencing Growth In The Antispasmodics Drugs Market?

In the antispasmodic drugs market, one of the key trends that facilitates growth is product innovation. Major companies in the market are focusing on the development of unique solutions to solidify their market presence. For example, in April 2022, Ardelyx Inc., a biopharmaceutical corporation based in the US, launched IBSRELA, an NHE-3 inhibitor that is used for the treatment of people suffering from irritable bowel syndrome with constipation (IBS-C). The product provides a fresh therapeutic option with a unique mechanism of action and impressive efficacy in addressing constipation and various abdominal symptoms commonly found in IBS-C patients, as confirmed by Phase 3 clinical trials.

Who Are The Main Participants Shaping The Antispasmodics Drugs Market Landscape?

Major companies operating in the antispasmodics drugs market include Daiichi Sankyo Company Limited, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson Services Inc., Pfizer Inc., Shanghai Fosun Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Akorn Inc., Aurobindo Pharma Limited, Lannett Company Inc., Nexus Pharmaceuticals Inc., Actiza Pharmaceutical Private Limited, Blue Cross Laboratories Pvt. Ltd., Dr. Reddy’s Laboratories Ltd., Lexicare Pharma Pvt. Ltd., Solitaire Pharmacia Private Limited, Strides Pharma Science Limited, Wellona Pharma Private Limited, SunGen Pharma LLC, GlaxoSmithKline plc, Novartis AG, Sanofi SA, AstraZeneca plc, Merck & Co. Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antispasmodics-drugs-global-market-report

Which Region Currently Holds The Largest Share In The Antispasmodics Drugs Market?

North America was the largest region in the antispasmodics drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the antispasmodics drugs market report during the forecast period. The regions covered in the antispasmodics drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9414&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model